ArticleThe Lancet regional health. Europe2025

Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial.

Mads Gamborg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.